Skip to main content
InNexus Biotechnology Inc. logo

InNexus Biotechnology Inc. — Investor Relations & Filings

Ticker · IXSBF ISIN · CA45771Q1046 TSXV Professional, scientific and technical activities
Filings indexed 0 across all filing types
Latest filing no filings yet
Country CA Canada
Listing TSXV IXSBF

About InNexus Biotechnology Inc.

https://www.innexusbiotech.com/

InNexus Biotechnology Inc. was a development-stage biotechnology company specializing in the commercialization of enhanced monoclonal antibodies (mAbs). The company's core technological asset was the proprietary DXL™ platform, engineered to improve the performance and efficacy of therapeutic antibodies. InNexus applied this technology to develop drug candidates within the therapeutic antibody space and also leveraged it to establish a diagnostics business. The company pursued its pipeline development through internal research and external collaborations, notably engaging with organizations such as the National Cancer Institute.

Recent filings

No filings indexed yet

We are still gathering filings for InNexus Biotechnology Inc.. .

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.